Course #MED27053.
OBJECTIVES
Upon completion of this activity, the participant will be able to:
Use an evidence-based approach to multimodal analgesia in children
Explain the optimal approach to chronic pain in children
Describe the essential five “bundled” components of needle pain management
Develop strategies to identify youth and families at risk for opioid related adverse outcomes and approaches to reduce these risks
Develop strategies to diagnose and treat pediatric/adolescent substance use disorder
Describe components of successful chronic pain management without opioids and further testing/imaging in pediatric patients with chronic pain
Compare the effectiveness and harms of cannabinoids in treatment of pediatric pain
PROGRAM
FEES
The cost to participate in this activity is $75.00.
COURSE DIRECTOR
Stefan Friedrichsdorf, MD, FAAPProfessor of PediatricsUniversity of California, San Francisco
ORGANIZING COMMITTEE
Jeffrey Tabas, MDProfessor of Emergency MedicineZuckerberg San Francisco General Hospital and Trauma CenterTymothi PetersDirector, Office of Continuing Medical EducationJoey Bernal, MAManager, Continuing Certification and Special Projects
FACULTY
Donna Eull, PhD, MA, RN, CHPPNClinical Associate ProfessorUniversity of Minnesota School of NursingMinneapolis, Minnesota
Stefan Friedrichsdorf, MD, FAAPProfessor of PediatricsUniversity of California, San FranciscoLucien Gonzalez, MD, MS, FAAPAssociate Professor, General Pediatrics & Adolescent MedicineUniversity of North Carolina School of MedicineChapel Hill, North CarolinaTerri Voepel-Lewis, PhD, RN, FAANAssociate Research ScientistDepartment of AnesthesiologyMichigan Medicine, University of MichiganAnn Arbor, Michigan
DISCLOSURE
None of the content planners, staff, reviewers, nor others in control of content has disclosed relevant financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
ACCREDITATION
In support of improving patient care, the University of California, San Francisco is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians: UCSF designates this enduring material for a maximum of 8.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.>> Please see information concerning Maintenance of Certification/Continuing Certification Credit below.Nurse Practitioners and Registered Nurses: This course is available for 8.00 Nurse Contact Hours as designated by the ANCC. This activity is designated for a maximum of 5.25 pharmacotherapeutic hours (0.525 CEU's) towards meeting the requirement for nursing pharmacology continuing education. Nurses should claim 0.1 CEUs for each contact hour of participation in designated pharmacotherapeutic continuing education.
Physician Assistants: The National Commission on Certification of Physician Assistants (NCCPA) states that AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification.
Pharmacists: This activity has been approved for 8.0 contact hours under the Universal Activity Number JA0000302-0000-230002-H08-P. Credits will be reported to CPE Monitor within 2-3 weeks of completion of the course.California Psychologists: This educational activity is recognized by the California Board of Psychology as meeting the continuing education requirements toward license renewal for California psychologists. Psychologists are responsible for reporting their own attendance to the California Board of Psychology. Psychologists from other states should check with their respective licensing boards.
This CME/CE opportunity meets the Medication Access and Training Expansion (MATE) Act requirements from the Substance Abuse and Mental Health Services Administration (SAMHSA) for Drug Enforcement Administration (DEA) training on substance use disorders. Providers planning to receive or renew their DEA registration can earn 8.0 hours towards their one-time eight-hour MATE requirement by completing the entire activity.This CME activity meets the requirements under California Assembly Bill 1195, continuing education and cultural and linguistic competency.Approved credits include 8.0 toward meeting the requirement under California Assembly Bill 487, Pain Management and End-of-Life Care.
CLAIMING CREDIT
Participants must view the online recordings and complete the evaluation form online to receive a certificate. Your certificate will be available immediately for print or download upon completion of the entire activity. Certificates are not proof of participation for pharmacists; credits will be reported through CPE Monitor.Maintenance of Certification / Continuing Certification InformationSuccessful completion of this CME activity, which includes participation in the evaluationcomponent, enables the participant to earn up to 8 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program.It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting any of the MOC credits listed above. You must provide your diplomate number and month and day of birth to claim MOC/CC points.
RESOURCES
Cultural and Linguistic Competency Resources CLC Info and ResourcesUC Online Privacy Policyhttp://meded.ucsf.edu/cme/privacy-policy